Acute generalised exanthematous pustulosis

Australasian Journal of Dermatology

Volumn 53, Issue 2, 2012, Pages 87-92

  Fernando, Suran L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

acute generalised exanthematous pustulosis; drug allergy; severe cutaneous adverse reactions

Indexed keywords

AMINOPENICILLIN; ANTIBIOTIC AGENT; BUFEXAMAC; CORTICOSTEROID; DILTIAZEM; EPIDERMIN; HYDROXYCHLOROQUINE; MERCURY; PRISTINAMYCIN; SULFONAMIDE; TERBINAFINE;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; DRUG SAFETY; FEVER; HISTOLOGY; HUMAN; INCIDENCE; KERATINOCYTE; MORTALITY; NEUTROPHILIA; PATCH TEST; PATHOGENESIS; PUSTULE; REVIEW;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; HUMANS;

EID: 84861092443     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2011.00845.x     Document Type: Review

References (32)

1. Beylot C, Bioulac P, Doutre MS,. Pustuloses exanthématiques aiguës généralisées, à propos de 4 cas. Ann. Dermatol. Venereol. 1980; 107: 37-48. (Pubitemid 10061855)
2. Sidoroff A, Halevy S, Bavinck JN, et al,. Acute generalized exanthematous pustulosis (AGEP)-a clinical reaction pattern. J. Cutan. Pathol. 2001; 28: 113-19. (Pubitemid 32112994)
3. Sidoroff A, Dunant A, Viboud C, et al,. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br. J. Dermatol. 2007; 157: 989-96. (Pubitemid 47583506)
4. Chang SL, Huang YH, Yang CH, et al,. Clinical manifestations and characteristics of patients with acute generalized exanthematous pustulosis in Asia. Acta Derm. Venereol. 2008; 88: 363-5.
5. Davidovici B, Dodiuk-Gad R, Rozenman D, et al,. Profile of acute generalized exanthematous pustulosis in Israel during 2002-2005: results of the RegiSCAR Study. Isr. Med. Assoc. J. 2008; 10: 410-12.
6. Zhang JL, Chen X, Li J, et al,. [Clinical analysis of childhood acute generalized exanthematous pustulosis. Zhongguo Dang Dai Er Ke Za Zhi 2008; 10: 497-9.
7. Roujeau JC,. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209: 123-9.
8. Brandenburg VM, Kurts C, Eitner F, et al,. Acute reversible renal failure in acute generalized exanthematous pustulosis. Nephrol. Dial. Transplant. 2002; 17: 1857-8. (Pubitemid 35174311)
9. Belhadjali H, Mandhouj S, Moussa A, et al,. Mercury-induced acute generalized exanthematous pustulosis misdiagnosed as a drug-related case. Contact Dermatitis 2008; 59: 52-4. (Pubitemid 351990034)
10. Belhadjali H, Ghannouchi N, Njim L, et al,. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl. Contact Dermatitis 2008; 58: 247-8. (Pubitemid 351421751)
11. Rouchouse B, Bonnefoy M, Pallot B, et al,. Acute generalized exanthematous pustular dermatitis and viral infection. Dermatologica 1986; 173: 180-4. (Pubitemid 16029490)
12. Feio AB, Apetato M, Costa MM, et al,. [Acute generalized exanthematous pustulosis due to Coxsackie B4 virus]. (in Portuguese). Acta Med. Port. 1997; 10: 487-91. (Pubitemid 127521325)
13. Haro-Gabaldon V, Sanchez-Sanchez-Vizcaino J, Ruiz-Avila P, et al,. Acute generalized exanthematous pustulosis with cytomegalovirus infection. Int. J. Dermatol. 1996; 35: 735-7. (Pubitemid 26356128)
14. Naides SJ,. Rheumatic manifestations of parvovirus B19 infection. Rheum. Dis. Clin. North Am. 1998; 24: 375-401. (Pubitemid 28256644)
15. Manzano S, Guggisberg D, Hammann C, et al,. [Acute generalized exanthematous pustulosis: first case associated with a Chlamydia pneumoniae infection]. (In French) Arch. Pediatr. 2006; 13: 1230-2. (Pubitemid 44348942)
16. Klein N, Hartmann M, Helmbold P, et al,. [Acute generalized exanthematous pustulosis associated with recurrent urinary tract infections]. (In German) Hautarzt 2009; 60: 226-8.
17. Davidovici BB, Pavel D, Cagnano E, et al,. Acute generalized exanthematous pustulosis following a spider bite: report of 3 cases. J. Am. Acad. Dermatol. 2006; 55: 525-9. (Pubitemid 44189600)
18. Birnie AJ, Litlewood SM,. Acute generalized exanthematous pustulosis does not always have a drug-related cause. Br. J. Dermatol. 2008; 159: 492-3. (Pubitemid 352009837)
19. Schmid S, Kuechler PC, Britschgi M, et al,. Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation. Am. J. Pathol. 2002; 161: 2079-86. (Pubitemid 35434854)
20. Schaerli P, Britschgi M, Keller M, et al,. Characterization of human T cells that regulate neutrophilic skin inflammation. J. Immunol. 2004; 173: 2151-8. (Pubitemid 38971654)
21. Lazarov A, Livni E, Halevy S,. Generalized pustular drug eruptions: confirmation by in vitro tests. J. Eur. Acad. Dermatol. Venereol. 1998; 10: 36-41. (Pubitemid 28076353)
22. Halevy S, Cohen A, Livni E,. Acute generalized exanthematous pustulosis associated with polysensitivity to paracetamol and bromhexine: the diagnostic role of in vitro interferon-gamma release test. Clin. Exp. Dermatol. 2000; 25: 652-4. (Pubitemid 32105492)
23. Girardi M, Duncan KO, Tigelaar RE, et al,. Cross-comparison of patch test and lymphocyte proliferation responses in patients with a history of acute generalized exanthematous pustulosis. Am. J. Dermatopathol. 2005; 27: 343-6. (Pubitemid 41232490)
24. Britschgi M, Steiner UC, Schmid S, et al,. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J. Clin. Invest. 2001; 107: 1433-41. (Pubitemid 32522037)
25. Choi MJ, Kim HS, Park HJ, et al,. Patients with acute generalized exanthematous pustulosis: a case series and review of the literature. Ann. Dermatol. 2010; 22: 163-9.
26. Wolkenstein P, Chosidow O, Flechet ML, et al,. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996; 35: 234-6. (Pubitemid 26408155)
27. Mashiah J, Brenner S,. A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis. Arch. Dermatol. 2003; 139: 1181-3. (Pubitemid 37128380)
28. Thomas E, Bellon T, Barranco P, et al,. Acute generalized exanthematous pustulosis due to tetrazepam. J. Investig. Allergol. Clin. Immunol. 2008; 18: 119-22. (Pubitemid 351872305)
29. Halevy S, Cohen AD, Grossman N,. Clinical implications of in vitro drug-induced interferon gamma release from peripheral blood lymphocytes in cutaneous adverse drug reactions. J. Am. Acad. Dermatol. 2005; 52: 254-61.
30. Kardaun SH, Kuiper H, Fidler V, et al,. The histopathological spectrum of acute generalized exanthematous pustulosis (AGEP) and its differentiation from generalized pustular psoriasis. J. Cutan. Pathol. 2010; 37: 1220-9.
31. Chen YC, Chiu HC, Chu CY,. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch. Dermatol. 2010; 146: 1373-9.
32. Tamir E, Wohl Y, Mashiah J, et al,. Acute generalized exanthematous pustulosis: a retrospective analysis showing a clear predilection for women. Skinmed 2006; 5: 186-8.